1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Tumor types and patient demographics
Tumor n M:F Mean age, y (min-max)
Medulloblastoma 33 23:10 6.49 (1.15–17.19)
Ependymoma^a 17 14:3 4.20 (0.46–17.18)
PA 38 18:20 6.86 (1.44–18.73)
AT/RT 8 5:3 1.01 (0.25–2.29)
Total 96 
Note:—M:F indicates male:female.
↵a Four anaplastic (WHO grade 3) and 13 WHO grade 2 ependymomas.
Tumor	n	M:F	Mean age, y (min-max)
Medulloblastoma	33	23:10	6.49 (1.15–17.19)
Ependymoma^a	17	14:3	4.20 (0.46–17.18)
PA	38	18:20	6.86 (1.44–18.73)
AT/RT	8	5:3	1.01 (0.25–2.29)
Total	96